| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b0e5f2d2b7b20ecee430e8ac22a95c4f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2030-027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-775
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54313
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5432
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-74 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2020-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b25cd0be96c405abe695d168907f218f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fc5c20c7bf73c841a70dd62fd2e6ff1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_441962f8a244c74e9ddf37600121183a |
| publicationDate |
2022-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-114025762-A |
| titleOfInvention |
A method for assessing cardiovascular or inflammatory disease risk using non-exchangeable lipid probes |
| abstract |
A method of assessing the risk of developing cardiovascular disease (CVD) or inflammatory disease in a patient comprising (i) incubating a sample of bodily fluid with a donor particle wherein the lipid and a first amount of detectably labeled non-exchangeable lipid are used A probe (NELP) coats the donor particle; (ii) separates detectably labeled NELP-associated HDL into a first fraction and the donor particle into a second fraction; (iii) measures the a second amount of detectably labeled NELP in the first portion; (iv) determining a detectably labeled NELP efflux value for the patient; and (v) comparing the patient's detectably labeled NELP efflux value to a reference standard for comparison. Also provided are related methods of reducing the risk of developing CVD or inflammatory disease in a patient and methods of measuring the amount of functional HDL in a body fluid sample. |
| priorityDate |
2019-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |